BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25485472)

  • 1. Soluble coxsackievirus B3 3C protease inhibitor prevents cardiomyopathy in an experimental chronic myocarditis murine model.
    Lim BK; Yun SH; Ju ES; Kim BK; Lee YJ; Yoo DK; Kim YC; Jeon ES
    Virus Res; 2015 Mar; 199():1-8. PubMed ID: 25485472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral activity of coxsackievirus B3 3C protease inhibitor in experimental murine myocarditis.
    Yun SH; Lee WG; Kim YC; Ju ES; Lim BK; Choi JO; Kim DK; Jeon ES
    J Infect Dis; 2012 Feb; 205(3):491-7. PubMed ID: 22207647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of RNA Helicase Activity Prevents Coxsackievirus B3-Induced Myocarditis in Human iPS Cardiomyocytes.
    Yun SH; Shin HH; Ju ES; Lee YJ; Lim BK; Jeon ES
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy.
    Pinkert S; Dieringer B; Klopfleisch R; Savvatis K; Van Linthout S; Pryshliak M; Tschöpe C; Klingel K; Kurreck J; Beling A; Fechner H
    Circ Heart Fail; 2019 Nov; 12(11):e005250. PubMed ID: 31718319
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Lee YG; Park JH; Jeon ES; Kim JH; Lim BK
    J Microbiol Biotechnol; 2016 Nov; 26(11):2012-2018. PubMed ID: 27558433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of cardiac dysfunction in acute coxsackievirus B3 cardiomyopathy by inducible expression of a soluble coxsackievirus-adenovirus receptor.
    Pinkert S; Westermann D; Wang X; Klingel K; Dörner A; Savvatis K; Grössl T; Krohn S; Tschöpe C; Zeichhardt H; Kotsch K; Weitmann K; Hoffmann W; Schultheiss HP; Spiller OB; Poller W; Fechner H
    Circulation; 2009 Dec; 120(23):2358-66. PubMed ID: 19933937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of RNA interference and virus receptor trap exerts additive antiviral activity in coxsackievirus B3-induced myocarditis in mice.
    Stein EA; Pinkert S; Becher PM; Geisler A; Zeichhardt H; Klopfleisch R; Poller W; Tschöpe C; Lassner D; Fechner H; Kurreck J
    J Infect Dis; 2015 Feb; 211(4):613-22. PubMed ID: 25193982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasudil exerts a cardio-protective effect on mice with coxsackievirus B3-induced acute viral myocarditis.
    Dai K; Wang Y; Tai S; Ni H; Lian H; Yu Y; Liao W; Zheng C; Chen Q; Kuver A; Li J
    Cardiovasc Ther; 2018 Dec; 36(6):e12477. PubMed ID: 30380183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
    Schmidtke M; Merkle I; Klingel K; Hammerschmidt E; Zautner AE; Wutzler P
    J Med Virol; 2007 Sep; 79(9):1334-42. PubMed ID: 17607777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration.
    Song X; Liu Z; Wang H; Xin Y; Wang X; Chen J; Shi Y; Zhang C; Hui R
    Exp Biol Med (Maywood); 2007 Dec; 232(11):1441-8. PubMed ID: 18040068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of losartan in mice with chronic viral myocarditis induced by coxsackievirus B3.
    Zhang YY; Li JN; Xia HH; Zhang SL; Zhong J; Wu YY; Miao SK; Zhou LM
    Life Sci; 2013 Jul; 92(24-26):1186-94. PubMed ID: 23702425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of Endoplasmic Reticulum Stress-Mediated C/EBP Homologous Protein Activation in Coxsackievirus B3-Induced Acute Viral Myocarditis.
    Cai Z; Shen L; Ma H; Yang J; Yang D; Chen H; Wei J; Lu Q; Wang DW; Xiang M; Wang J
    Circ Heart Fail; 2015 Jul; 8(4):809-18. PubMed ID: 25985795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of 20(s)-protopanaxtriol on viral myocarditis infected by coxsackievirus B3.
    Wang X; Wang Y; Ren Z; Qian C; Li Y; Wang Q; Zhang Y; Zheng L; Jiang J; Yang C; Wang D; Zhang Y; Fan J; Wang Y
    Pathobiology; 2012; 79(6):285-9. PubMed ID: 22688124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteasome inhibition attenuates coxsackievirus-induced myocardial damage in mice.
    Gao G; Zhang J; Si X; Wong J; Cheung C; McManus B; Luo H
    Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H401-8. PubMed ID: 18515649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2,3,4-Trihydroxybenzyl-hydrazide analogues as novel potent coxsackievirus B3 3C protease inhibitors.
    Kim BK; Ko H; Jeon ES; Ju ES; Jeong LS; Kim YC
    Eur J Med Chem; 2016 Sep; 120():202-16. PubMed ID: 27191615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitin-like protein ISG15 (interferon-stimulated gene of 15 kDa) in host defense against heart failure in a mouse model of virus-induced cardiomyopathy.
    Rahnefeld A; Klingel K; Schuermann A; Diny NL; Althof N; Lindner A; Bleienheuft P; Savvatis K; Respondek D; Opitz E; Ketscher L; Sauter M; Seifert U; Tschöpe C; Poller W; Knobeloch KP; Voigt A
    Circulation; 2014 Oct; 130(18):1589-600. PubMed ID: 25165091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithium chloride confers protection against viral myocarditis via suppression of coxsackievirus B3 virus replication.
    Zhao Y; Yan K; Wang Y; Cai J; Wei L; Li S; Xu W; Li M
    Microb Pathog; 2020 Jul; 144():104169. PubMed ID: 32205210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the acute defence reaction by eplerenone prevents cardiac disease progression in viral myocarditis.
    Tschöpe C; Van Linthout S; Jäger S; Arndt R; Trippel T; Müller I; Elsanhoury A; Rutschow S; Anker SD; Schultheiss HP; Pauschinger M; Spillmann F; Pappritz K
    ESC Heart Fail; 2020 Oct; 7(5):2838-2852. PubMed ID: 32662949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colchicine aggravates coxsackievirus B3 infection in mice.
    Smilde BJ; Woudstra L; Fong Hing G; Wouters D; Zeerleder S; Murk JL; van Ham M; Heymans S; Juffermans LJ; van Rossum AC; Niessen HW; Krijnen PA; Emmens RW
    Int J Cardiol; 2016 Aug; 216():58-65. PubMed ID: 27140338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus receptor trap neutralizes coxsackievirus in experimental murine viral myocarditis.
    Lim BK; Choi JH; Nam JH; Gil CO; Shin JO; Yun SH; Kim DK; Jeon ES
    Cardiovasc Res; 2006 Aug; 71(3):517-26. PubMed ID: 16806133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.